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1 
INTRODUCTION  
 
Laryngoscopy and endotracheal intubation is one of the key skills in 
anesthesiology. 
 Sir William Maceven, a Scottish surgeon was the first to perform 
endotracheal intubation in 1880. American otolaryngologist Dr. 
Chevallier Jackson developed the scientific principles of laryngoscopy 
and endotracheal intubation. The occurrence of hemodynamic response to 
laryngoscopy and intubation was evident after the advent of neuro 
muscular relaxant. 
The act of laryngoscopy and intubation elicits reflex tachycardia 
and  hypertension. Though this stress response is transient, it is profound 
enough to cause undesired effects on cardiovascular system like 
dysrhythmias, and myocardial ischemia
1
. Hence, this laryngoscopy and 
intubation induced stress response needs to be attenuated. 
 The reflex response to instrumentation of airway is sympathetic 
rather than a vasovagal response. The previous studies which showed 
increase in serum catecholamine level during laryngoscopy and 
intubation supports the fact that the reflex response is sympathetic
2
. 
Blunting of the stress response by beta receptor blockade, further 
confirms this concept. 
  
2 
The various pharmacological methods to attenuate hemodynamic stress 
response to laryngoscopy and tracheal intubation are listed below. The 
efficacy and adverse effects of these techniques varies, with none of the 
method being superior to another. 
 Beta receptor blocking drugs 
 Calcium channel blocking drugs 
 Topical or parenteral lignocaine 
 Opioids like fentanyl or remifentanil 
 Vasodilating drugs 
 Deepening the level of anesthesia 
 Omitting anticholinergic premedication 
Gabapentenoid group of drugs: 
Gabapentenoid group of drugs includes Gabapentin and Pregabalin. They 
are structurally related to the inhibitory neurotransmitter gamma amino 
butryric acid (GABA). These drugs possess anticonvulsant, sedative, 
anxiolytic, and antihyperalgesic effects. Pregabalin is approved by FDA 
for use as adjunctive therapy in partial seizure, chronic pain syndromes 
like diabetic neuropathic pain, and post herpetic neuralgia. Studies have 
been done regarding potential perioperative use of gabapentenoids. 
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Pregabalin:  
Pregabalin has similar structure and mechanism of action as 
gabapentin. Recent studies have evaluated the role of Pregabalin 
premedication on anxiolysis, attenuation of stress response to 
laryngoscopy and opioid sparing effect. These studies claim favourable 
response to Pregabalin and absence of significant side effects.  
 Potential perioperative use of Pregabalin: 
Clinical investigations done with Pregabalin premedication have 
concluded that it produces useful preoperative sedation, anxiolysis, and 
attenuates pressor response to laryngoscopy and intubation. The exact 
mechanism by which Pregabalin attenuates laryngoscopic stress response 
is not known. Blunting the release of excitatory neuro aminoacids, due to 
blockade of alpha2 delta subunit of neuronal calcium channels could be 
the possible mechanism
3
. 
Pregabalin as an adjuvant in acute pain management: 
Adjuvants are substances which by themselves are ineffective, but when 
combined with opioids, they reduce the opioid requirement and thereby 
its adverse effects. There is heightened interest in the evaluation of 
Pregabalin as a good adjuvant to opioids.  
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Surgical pain causes a hyper excitation phenomenon by simulating 
the pain pathways and this increases the magnitude of post-operative pain 
with consequent increase in opioid requirement. By blunting this hyper 
excitation phenomenon, Pregabalin produces an antihyperalgesic effect. 
There are several studies which evaluated various doses of 
gabapentin on attenuation of laryngoscopic stress response and its effect 
on acute pain management. But there are only limited studies done with 
pregabalin regarding the same clinical implications. 
This study was designed to evaluate the efficacy of single oral dose 
of 150mg pregabalin given one hour before induction on the attenuation 
of hemodynamic response to tracheal intubation and the requirement of 
fentanyl in the early post-operative period and its side effects. 
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AIM OF THE STUDY     
 
 The aim of this study was to evaluate the efficacy and safety of 
Pregabalin premedication, administered as a single 150 mg oral capsule 
an hour before surgery on the following features,   
1. The potential perioperative benefits. 
2. Efficacy of attenuation of hemodynamic stress response to 
laryngoscopy and intubation. 
3. Interference on recovery from general anesthesia. 
4. Postoperative patient controlled analgesic (PCA) requirement of 
Fentanyl over the first 12 hours after surgery. 
5. Adverse effects of Pregabalin. 
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ANATOMY OF UPPER AIRWAY
4
   
 
The upper airway comprises of mouth, nasopharynx, oropharnnx, and 
larynx. This is the most vulnerable area to obstruction and may get 
traumatised during laryngoscopy. Pharynx is a fibro muscular tube that 
extends from the base of the skull to the lower border of cricoid cartilage. 
Nerve supply to upper airway: 
The sensory nerve supply to the upper airway is derived from the 
cranial nerves. The mucous membrane of the nose is supplied by 
ophthalmic division of trigeminal nerve anteriorly and by the maxillary 
division posteriorly. Soft palate and hard palate are supplied by the 
palatine branches of trigeminal nerve. 
 Anterior two-third of tongue gets general sensation from lingual 
nerve, a branch of mandibular division of trigeminal, and taste sensation 
from branches of facial nerve. Posterior third of tongue gets general and 
taste sensation both from glossopharyngeal nerve. 
The glossopharyngeal nerve also innervates the roof of pharynx, 
tonsils, and the under surface of soft palate. The vagus provides sensation 
below epiglottis. The pharyngeal surface of epiglottis is supplied by 
glossopharyngeal and the laryngeal surface by the vagus nerve.  
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The superior laryngeal branch of vagus divides into external and 
internal laryngeal nerve. The superior laryngeal nerve gives motor branch 
to the cricothyroid muscle. All other muscles of larynx are supplied by 
recurrent laryngeal nerve. 
The sensory supply of larynx from epiglottis to vocal cords is 
supplied by internal laryngeal nerve. Sensation below vocal cords and 
trachea is supplied by the recurrent laryngeal branch of vagus. 
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PHYSIOLOGY OF HEMODYNAMIC RESPONSE TO 
LARYNGOSCOPY AND INTUBATION
5 
 
Hemodynamic response occurs during the act of laryngoscopy and to 
subsequent tracheal intubation. These responses are transient but 
profound enough to cause morbidity and mortality. Tachycardia and 
hypertension response are the common hemodynamic response. These 
circulatory changes are detrimental in elderly, hypertensive, and ischemic 
heart disease patients leading on to myocardial infarction or 
dysrhythmias. 
Cardiovascular response 
 The unpredictable cardiovascular response to upper airway 
stimulation can be both sympathetically and Para sympathetically 
mediated. The occurrence of bradycardia in neonates and infants is 
mediated by increase in vagal tone at the SA node and is virtually a 
monosynaptic response. 
 But the more common tachycardia and hypertension response is 
mediated by discharge from sympathetic efferent through 
cardioaccelerator fibres and sympathetic chain ganglion. 
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The afferent impulses from IX to X cranial nerves carried to the 
sympathetic nervous system via brain stem and spinal cord are 
polysynaptic in nature. This results in diffuse autonomic response which 
includes the release of norepinephrine form adrenergic nerves and 
epinephrine from adrenal medulla. Release of renin from juxta-
glomerular apparatus due to activation of renin angiotensin system is also 
a proposed mechanism. 
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PHARMACOLOGY OF PREGABALIN
6,7 
 
Pregabalin belongs to gabapentenoid group of drugs. It possesses 
chemical structure similar to inhibitory neurotransmitter GABA (gamma 
amino benzoic acid). Pregabalin has got similar properties like the 
prototype drug gabapentin. 
  
Fig-1: Chemical structure of Pregabalin 
 
  
Pregabalin which is chemically S-(+)-3-isobutylgaba (Fig-1), was 
designed as a lipophilic analogue of GABA (gamma-aminobutyric acid) 
substituted at the 3-position to facilitate diffusion across blood brain 
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barrier. 3-isobutylgaba exists in isomeric forms, rendering the drug 
pharmacologically active enantiomer. 
Drug approval
6 
 
 July 2004–European Commission, granted the pharmaceutical 
company Pfizer approval for pregabalin, for the treatment of 
peripheral neuropathy and as an adjunctive therapy for partial 
seizures in patients with epilepsy. 
 December 2004-The Food and Drug Administration (FDA) 
approved pregabalin, for the treatment of neuropathic pain 
associated with diabetic peripheral neuropathy and post herpetic 
neuralgia.  
 June 2005-The FDA approved pregabalin for use as an adjuvant 
in partial seizure treatment. 
 March 2006- Pregabalin got approval from European 
commission, for the treatment of generalised anxiety disorder  
 Pregabalin is placed in Schedule V of the controlled substance 
act, based on the report of euphoria in controlled clinical trials. 
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Mechanism of action:  
Pregabalin is only structurally related to the inhibitory 
neurotransmitter GABA. It neither acts on GABA receptor, nor mimics 
it physiologically. The precise mode of action of pregabalin has not 
been fully elucidated. Pregabalin has got similar pharmacological 
profile as gabapentin. The main site of action of pregabalin is on the 
alpha 2 delta subunit of neuronal calcium channels. 
Pregabalin is an alpha 2 delta ligand
7 
 Alpha 2 delta is a subunit of presynaptic, voltage-gated calcium 
channel. The main site of action of pregabalin is this alpha 2 delta 
subunit of neuronal calcium channels. This binding reduces the 
depolarisation induced calcium influx at nerve terminals. As a 
consequence, there is reduction in the release of several excitatory 
aminoacids, like glutamate, noradrenaline, substance-P, and CGRP. 
This modulation of neurotransmitter release by pregabalin contributes 
to its anticonvulsant, anxiolytic, and analgesic property. 
 Voltage gated calcium channels are divided into six types P, Q, N, 
L, R, and T-type channels. N-type calcium channels are involved in 
pain sensitization phenomenon in response to noxious stimuli. Calcium 
channel blockers like nifedipine binds to L-type channels, whereas 
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pregabalin binds to N-type. Cardiac and other peripheral tissues have L-
type calcium channels. This explains the lack of cardiovascular side 
effects with pregabalin. 
Fig-2: Structure of calcium channel  
 
 
Dosage and administration:   
 For painful diabetic peripheral neuropathy, the maximum 
recommended dosage is 100 mg thrice a day. Because pregabalin is 
eliminated primarily by renal excretion, the dose needs to be reduced in 
patients with reduced renal function. For peripheral neuropathy, dosing 
should begin at 75 mg per day, and may be increased to 300 mg per day 
within a week based on efficacy and tolerability. 
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Pharmacokinetics  
Pregabalin has consistent dose proportional pharmacokinetics
 
The mean elimination half-life of pregabalin is 6.3 hours, and is 
independent of dose and repeated administration. This consistent dose-
proportional pharmacokinetics of pregabalin provides confidence in the 
prediction of dose-response relationship in clinical practice. 
Administration of pregabalin with food has no effect on its absorption 
(13). 
Distribution, metabolism, and elimination 
L-transporter is an important system which is responsible for 
transport of substances across the brain and gut. Pregabalin is a substrate 
of this system and hence crosses blood brain barrier rapidly. This 
property is essential for a drug that influences central nervous system 
activity. 
In humans, pregabalin undergoes less than 2% metabolism. It is 
excreted unchanged by the kidneys. In patients with compromised renal 
function the dose of pregabalin needs to be reduced. In patients with 
creatinine clearance between 30 to 60 ml/minute, daily dose of pregabalin 
needs to be reduced by 50% when compared to patients with creatinine 
clearance more than 60 ml/minute. 
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Pregabalin versus gabapentin 
Though pregabalin and gabapentin belongs to same group and possesses 
similar chemical structure, pregabalin has better pharmacokinetic 
properties.  
Table-1: Pharmacological properties of pregabalin
7
  
Property  Clinical significance 
 
1. High affinity for α2δ receptor 
2. No effect on GABA  
3. Linear dose proportional Cmax 
4. Lack of protein binding 
5. Negligible metabolism 
6. Renal excretion (98% 
unchanged) 
 
7. Rapidly cross blood brain barrier  
 
New mechanism of action 
No retinal or optic nerve toxicity 
Predictable level and dose response 
No drug interactions 
No drug interactions  
Dose reduction in renal impairment 
No hepatic effects 
Access to CNS site of action 
Cmax – maximal plasma concentration 
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Pregabalin lacks drug-drug interactions: 
Pregabalin does not bind to plasma proteins and is not subjected to 
hepatic metabolism. Studies done on human liver microsomes have 
demonstrated that pregabalin does not affect the cytochrome P450 
system.  
These facts indicate that pregabalin is unlikely to cause 
pharmacokinetic drug interactions. This property is important when 
administering pregabalin with other anticonvulsant drugs. 
 
Safety implications of pregabalin: 
Pregabalin does not completely block calcium channel function or 
transmitter release, even at high concentration. This property could have 
important safety implications in case of drug overdose.  
Alpha 2 delta ligands acts on N-type calcium channels, and have 
little  effect on voltage gated calcium channels of heart (L-type), or other 
peripheral tissues. Hence, pregabalin has no effect on arterial blood 
pressure or cardiac function at therapeutic doses. 
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Clinical uses of pregabalin 
 
1. Highly effective adjunctive therapy in the treatment of partial 
seizures 
2. Chronic pain syndromes like, diabetic peripheral neuropathy, and 
post herpetic neuralgia. 
3. Chronic anxiety disorder 
4. Adjuvant in acute pain management 
 
Since pregabalin possess anticonvulsant, sedative, analgesic, and anti-
hyperalgesic properties, studies are being done on potential perioperative 
uses like pre-operative sedation, anxiolysis, reduced inter-operative 
opioid requirement, and attenuation of hemodynamic stress response to 
laryngoscopy and tracheal intubation. 
 Alpha 2 delta receptor seems to be involved in the phenomenon of 
neuronal hypersensitisation to noxious stimuli. Blunting of this 
hypersensitisation by pregabalin helps in reducing the intensity of post-
operative pain and has got opioid sparing effect. 
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Side effects and precautions 
Pregabalin is a well-tolerated, relatively safe drug with dose-dependent 
adverse effects which are mild to moderate and usually transient. 
1. Dizziness (29%) 
2. Somnolence (22%) 
3. Dryness of mouth (9.1%) 
4. Blurred vision (6.4%) 
5. Edema (6.1%) 
6. Weight gain (5.6%) 
7.  Abnormal thoughts (5.4%) 
There are case reports of myoclonus, gynaecomastia, and a single case 
report of carpus callosum edema. Withdrawal of pregabalin after long 
term therapy should be gradual as it may potentiate seizure activity. 
 Pregabalin is contraindicated in patients with history of allergy to 
the drug or any of its components. FDA placed pregabalin in class C for 
pregnant patients. It is not recommended in pregnancy and breast feeding. 
Dose needs to be reduced in patients with reduced renal function. 
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PATIENT CONTROLLED ANALGESIA
8,9 
Widespread recognition of under treatment of acute pain by clinicians has 
led to the evaluation of practice guidelines for acute pain management by 
professional society like American society of anaesthesiologist (ASA). 
Anaesthesiologists who are very well aware of the importance of good 
pain control are the leaders in acute pain management services. 
 The various reasons for the inadequate control of pain includes the 
following reasons 
1. Wide interpatient and intrapatient variability in the need for 
analgesics. 
2. Variability in the plasma drug concentration, especially after 
intramuscular injections. 
3. Delay in administration of analgesics.  
Traditional intermittent injections of analgesic when required cannot 
compensate for these factors. 
Patient controlled analgesia, 
 Optimises delivery of analgesic drugs 
 Overcome the problem of pharmacokinetic variability among 
patients 
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 When patient experiences pain, he administers a bolus and when 
pain reduced there are no further demands. 
 
Patient controlled analgesia (PCA) is a method of offering the patients to 
self-administer the analgesic in a predetermined safe dosage as and when 
required. The route of administration and the choice of drug varies; 
intravenous PCA being the common mode. 
 Fig-3: Patient controlled analgesia device 
 
 
A PCA device can be programmed for several variables like 
 Demand dose – an optimal demand dose is essential for efficient 
PCA 
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 Lock-out interval – most interval range from 5 to 10minutes 
 Background infusion – generally not suggested for opioid naïve 
patients 
 
Austin deserves the credit for first clarifying the pharmacological 
concept of PCA. The smallest plasma concentration of the drug at which 
analgesia occurs is the minimum effective analgesic concentration 
(MEAC) which marks the difference between pain and analgesia. PCA 
maintains the plasma concentration within the effective analgesic range 
without peaks and troughs as in intermittent analgesic regimen.  
Fig-4: Minimum effective analgesic concentration 
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PCA provides, 
 Better quality of analgesia 
 Greater patient satisfaction 
 No difference in incidence of adverse effects 
 No difference in PACU or hospital stay 
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REVIEW OF LITERATURE    
The hemodynamic response to laryngoscopy and tracheal intubation, its 
physiological basis, the importance to attenuate these circulatory changes, 
and the various pharmacological methods to attenuate this response are 
extensively studied. 
Studies done on hemodynamic response to laryngoscopy and 
intubation 
Reid and Brace
10
  
In 1940, Reid and Brace suggested that irritant receptors are present in 
larynx, trachea, bronchi, and lungs. Mechanical stimulation of these 
receptors elicits a vasovagal response resulting in bradycardia, because 
both the afferent and efferent fibres were considered to be of vagal. 
Burstein
11
  
A decade later, Burstein and others using the same method of study in a 
large series of cases reached a different conclusion. They concluded that 
the majority of electrocardiographic changes during laryngoscopy and 
intubation were due to stimulation of cardioaccelerator fibres. 
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King.B.D, Harris LC, Greifenstein
12
   
Since electrocardiograph cannot reflect the functional status of the heart, 
continuous arterial pressure and heart rate monitoring was done by 
B.D.King. He found that, laryngoscopy alone can cause a pressor 
response. Insertion of tube into trachea further augments this effect and in 
addition capable of producing arrhythmia. He also excluded the retention 
of carbondioxide as a cause of sympathetic stimulation as it was a 
delayed response and not as abrupt as the laryngoscopic stress response. 
Hypertension was found to be due to increase in cadiac output due to 
increase in myocardial contractility and venous return, and increase in 
arteriolar resistance. Tachycardia occurred by stimulation of cardio 
accelerator fibres. 
Charles and Wycoff
13 
The hemodynamic response to laryngoscopy gained notice after the 
introduction of neuromuscular relaxants, as a part of balanced anesthesia. 
King and associates studied the stress response without the aid of muscle 
relaxants. Charles and Wycoff observed the influence of succinylcholine 
on the hemodynamic response to laryngoscopy. Succinylcholine 
produced transient rise in blood pressure and heart rate became more 
rapid. All these changes were not as abrupt as that caused by 
laryngoscopy, and returned to normal in one minute. 
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 The sympathoadrenal reflex response 
Prys-Roberts C, Greene L, Miloche
14 
Animal experiment done on cat by Timori and Widdicomb in 1969, 
demonstrated that the tachycardia and hypertension elicited by 
stimulation of respiratory tract was associated with enhanced neuronal 
activity in the cervical sympathetic efferent fibres. 
Shribman AJ, Smith G, Achola KJ
15 
Compared plasma catecholamine level and the cardiovascular response to 
laryngoscopy alone and those due to laryngoscopy and tracheal 
intubation. There was significant and similar increase in arterial pressure, 
heart rate, plasma noradrenaline and adrenaline level following 
laryngoscopy with or without intubation. Intubation however was 
associated with significant tachycardia, which did not occur with 
laryngoscopy alone.  
Derbyshire DR, Chmielewski A, Fell D
16 
Similar result was observed by Derbyshire, who reported increase in 
plasma catecholamine level concomitant with the hemodynamic response 
following laryngoscopy and intubation. Correlation between mean arterial 
pressure and catecholamine rise was significant when succinylcholine 
was used instead of pancuronium for intubation. 
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Morbidity caused by the hemodynamic stress response 
Kovac AL
17 
The hemodynamic response to laryngoscopy and intubation increases the 
cardiovascular and central nervous system morbidity.  
Low JM, Harvey JT, Prys-Roberts C
18 
Proved that hypertensive response to laryngoscopy was exaggerated and 
accompanied by markedly elevated plasma nor-epinephrine concentration 
in hypertensive patients. 
These hemodynamic swings prove dangerous to hypertensive patients, 
whose heart might be damaged by the hypertensive disease.  
John Bullington
19 
Studied the impact of advanced ageing on the hemodynamic response to 
laryngoscopy and shown that elderly patients have exaggerated 
sympathetic response to laryngoscopy accompanied by elevated plasma 
nor-epinephrine level. They had exaggerated hypertensive response and 
reduced chronotropic effect. He concluded that this could be because of 
reduced sensitivity of beta-1 receptors and normal alpha receptor 
sensitivity with advancing age. 
 
  
27 
Gabapentenoid group of drugs 
Noor M. Gajraj
6 
Gabapentenoid group of drugs includes Gabapentin and Pregabalin. They 
are   
relatively new group of drugs, which has got several clinical usefulness.    
Pregabalin is synthetic molecule, which is used as a highly effective 
adjuvant therapy in treatment of partial seizures, and in chronic pain 
syndromes like diabetic peripheral neuropathy, and post herpetic 
neuralgia. 
Kugler AR
20 
Pregabalin pharmacokinetic properties have been investigated in 28  
different pharmacology studies involving total of 472 subjects. They 
included dose ranging study from 1 mg to 300 mg. The results from these 
studies indicate that pregabalin has highly predictable and linear 
pharmacokinetics, with low interpatient variability. 
Elinor Ben Mechanam
7
  
Pregabalin is absorbed rapidly and extensively after oral dosing, with  
maximum plasma concentration occurring in approximately one hour 
after a single dose. The oral bioavailability is high at >90%, and is 
independent of the dosage. 
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Role of gabapentin on attenuation of laryngoscopic stress response 
Sherhat Koc, Dilek Memis, Necdet Sut
21 
Compared the efficacy of gabapentin alone and in combination with 
dexamethasone in attenuation of the laryngoscopic stress response. An 
hour before induction, one group received 800mg gabapentin orally, other 
group received 8mg dexamethasone alone intravenously, and third group 
along with 800mg gabapentin, received 8mg dexamethasone. Induction 
and maintenance of anesthesia was done in a standard manner with 
propofol and remifentanyl infusion. Heart rate and blood pressure were 
recorded before induction, and after tracheal intubation. Intraoperative 
opioid requirement was documented. Hemodynamic parameters and 
visual analogue scale were recorded over 24hours. Any adverse effects of 
the drug were noted 
Heart rate, blood pressure at 1minute, 3minutes, 5minutes, and 10minutes 
following intubation, remifentanyl consumption, and post-operative pain 
scores were all significantly lesser in patients who received 800mg 
gabapentin and 8mg dexamethasone. They did not observe any side 
effects like respiratory depression, vomiting, giddiness, during the first 
post-operative period.  They concluded that the hemodynamic response to 
laryngoscopy and intubation was less in gabapentin 800mg alone group 
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than the control group and significantly reduced when gabapentin 800mg 
was combined with 8mg dexamethasone. 
A. Fassoulakki, A. Melemeni, A. Paraskeva and G. Petropoulos
22 
This randomised placebo controlled study evaluated the effect of 1600mg 
gabapentin administered in four divided doses of 400mg each, starting on 
the noon of the day before surgery in patients undergoing abdominal 
hysterectomy under general anesthesia. 
 Anesthesia was induced with propofol and intubation facilitated 
with cis-atracurium 0.15mg/kg. They measured systolic, diastolic blood 
pressure and heart rate at baseline, 1, 3, 5, and 10minutes after intubation. 
They did not record the duration of each intubation and considered the 
Cormack Lehane grading as indication of difficulty of laryngoscopy. 
Patient’s characteristics were compared with Student’s t-test for unpaired 
observations. ANOVA with repeated measures were used to compare 
changes in blood pressure and heart rate. Systolic blood pressure differed 
with regard to group (p-0.003) and with regard to time (p-0.0001). Inter 
group comparison for each time point showed significantly higher 
systolic blood pressure values in control group. Diastolic blood pressure 
differed with respect to group (p-0.01) and with regard to time (p-
0.0001). Inter group comparison for each time point showed significantly 
higher diastolic blood pressure values in control group. Heart rate did not 
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differ with regard to group (p-0.269) but differed with regard to time (p-
0.0001). They concluded that gabapentin in the dose used attenuates 
pressor response to laryngoscopy and intubation. It has no effect on the 
changes in heart rate. 
Usha Bafna, Vipin K Goyal, Ashish Garg
23
  
Compared the efficacy of different doses of gabapentin on attenuation of 
pressor response to intubation. Patient undergoing elective surgeries 
under general anesthesia were divided into three groups. One group 
received 6oomg gabapentin, other group received 1000mg gabapentin 
administered 1hour prior to surgery, and were compared with placebo 
group.  
General anesthesia was induced with thiopentone and intubation was 
facilitated with succinylcholine. Anesthesia was maintained with 
Isoflurane and 66% nitrous oxide in oxygen and atracurium 0.1mg/kg. 
Laryngoscopy and intubations were performed by experienced 
anesthesiologist and the duration of laryngoscopy was limited to 
minimum possible time. 
Heart rate, arterial blood pressure was recorded. They did not score 
sedation and did not measure stress mediators such as endogenous plasma 
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catecholamines or cortisone, which they considered as limitation of the 
study. 
 Mean arterial pressure and heart rate were increased significantly 
after intubation in control and 600mg gabapentin group. There was 
significant decrease in mean blood pressure and heart rate in 1000mg 
gabapentin group. They concluded that 1000mg gabapentin administered 
an hour before induction significantly attenuated hemodynamic response 
to intubation. 
Evaluation of pregabalin premedication 
Paul F. White, Burcu Tufanogullari, Jimmie Taylor
24
  
They tested the hypothesis that premedication with oral pregabalin would 
produce useful preoperative sedation and anxiolysis in a dose related 
manner. Its effect on post-operative pain relief was their secondary 
objective. 
 This dose ranging study compared placebo group, 75mg, 150mg, 
and 300mg pregabalin given 1hour before induction. Patient’s level of 
anxiety, sedation, and pain were observed using 11 point verbal rating 
scale during intra-operative period and in PACU. Post-operative opioid 
requirement, occurrence of nausea and vomiting, the need for antiemetic, 
duration of PACU and hospital stay was recorded. They also did a seven 
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days follow up to record patient’s quality of recovery scores, and late 
recovery outcomes. 
 Post-operative fentanyl requirement, duration of PACU and 
hospital stay did not differ among groups. Anxiety level remained 
unchanged. Pregabalin 300mg produced significantly higher sedation 
score at the pre-induction period and at 90 and 120 minutes after surgery 
compared with control group. 
 They concluded that pregabalin premedication produces 
perioperative sedation in a dose related fashion, but failed to reduce 
anxiety, post-operative pain, or improve the recovery after minor elective 
surgery. 
Sundar AS, Rajeshkumar Kodali, Mahesh Vakamudi
25 
This clinical study evaluated and compared preoperative single dose 
pregabalin premedication to a placebo on attenuation of hemodynamic 
response to intubation, to assess perioperative requirement and side 
effects. Sixty adult patients undergoing off pump CABG were 
randomised into control group who received placebo capsule and study 
group who received 150mg pregabalin capsule 1hour before surgery.  
 The demographic data were comparable between the groups. 
Distribution of risk factors, like hypertension, diabetes, and history of 
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myocardial infarction in the two groups was not significant. The numbers 
of patients with regional wall motion abnormality between the groups 
were insignificant. 
 The baseline hemodynamic parameters were comparable between 
the two groups. The increase in heart rate was significantly higher in 
control group. A significant change in mean blood pressure was observed 
between the groups. It was higher in the control group. There were no 
significant differences in the post-operative fentanyl consumption. 
 This study observed that single dose oral pregabalin suppressed 
reflex tachycardia and hypertension due to laryngoscopy and tracheal 
intubation. The analgesic and opioid sparing effect was not apparent. It 
did not produce dizziness and visual disturbances. 
Rastogi Bhawna, Kumkum Gupta, Prashant K Gupta
3 
They studied ninety normotensive patients aged 24 to 56 years and were 
divided into placebo group, 75mg pregabalin group, and 150mg 
pregabalin group. The drug was administered 1hour before induction. 
Anesthetic technique was standardised. Pre-operative sedation level, 
hemodynamic parameters, and post-operative side effects were studied. 
 Preoperative sedation level was higher in premedication groups. 
Significant increase in heart rate and mean arterial pressure were seen in 
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placebo group and pregabalin 50mg group. The attenuation of heart rate 
and mean blood pressure were significant with 150mg pregabalin. Heart 
rate changes were not significant in any of the groups.  
They concluded that premedication with pregabalin sedated the patients 
adequately in a dose related manner. The hemodynamic stress response to 
laryngoscopy was significantly attenuated by 150mg pregabalin without 
increase in side effects. 
Kumkum Gupta, Deepak Sharma, Prashant Gupta
26 
They compared placebo with 150mg pregabalin and 300mcg clonidine on 
attenuation of pressor response to laryngoscopy and intubation in patients 
undergoing elective laparoscopic cholecystectomy. The test drugs were 
administered 75 to 90minutes prior to surgery as oral premedication. 
Group comparison was done for preoperative sedation, anxiety level 
along with changes in heart rate and mean blood pressure changes prior to 
and after induction, after laryngoscopy, pneumoperitoneum, and 
extubation. Intraoperative drug requirements and incidence of side effects 
were studied. 
 They concluded that 150mg pregabalin and 200mcg clonidine 
produced sedation and anxiolysis. It attenuated hemodynamic changes to 
laryngoscopy and tracheal intubation without causing in side effects. 
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Antihyperalgesic effect of pregabalin 
There are several studies done on the efficacy of pregabalin as good 
adjuvants in acute pain management. The opioid sparing effect pregabalin 
is because of the blocking of alpha 2 delta subunit of calcium channel, 
thereby preventing the hypersensitisation phenomenon.  
These studies compared different doses of pregabalin administered either 
as single dose or as multiple doses. Reduction of post-operative pain 
scores indicates good quality of analgesia, whereas reduction in total 
opioid dose consumed indicates opioid sparing effect. 
Mathieson O, Jacobsen LS, Holm HE
27
  
Mathieson investigated analgesic efficacy of pregabalin and 
dexamethasone in patients undergoing total hip replacement surgery 
under spinal anesthesia. Hundred and twenty patients were randomly 
allocated into three groups who receive placebo or 300mg pregabalin 
alone or with dexamethasone 8mg. patients received 1gm paracetamol an 
hour before surgery and later in post-operative period every 8hours. 
Patients were provided patient controlled (PCA) analgesia with2.5mg 
bolus of morphine. 
 Morphine requirement in first 24hours of surgery was reduced by 
50% in patients who received pregabalin alone and with dexamethasone. 
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Nausea and vomiting was less in dexamethasone group. Pregabalin 
produced excessive sedation at 300mg dosage. Addition of 
dexamethasone did not provide any additional benefits regarding pain 
control but reduced nausea and vomiting. 
R. Jokela, Ahonen J, Tallgren M
28 
Their study was based on the fact that multimodal analgesia improved the 
quality of post-operative pain management. They invested patients 
undergoing day-care laparoscopic gynaecological surgery. Pregabalin 
premedication in a dose of 75mg and 150mg were compared with 5mg 
diazepam. The post-operative analgesia was provided with 400mg 
Ibubrufen twice daily with intravenous fentanyl on request at recovery 
room. Paracetamol with codeine tablets after recovery room. 
 The visual analogue scale for pain at rest, at motion, on coughing 
and the amount of analgesics required over 24hours of after surgery were 
recorded. The area under curve (AUC) for VAS for pain at rest and at 
motion was significantly less with 150mg pregabalin. There was no 
difference in the amount of analgesics consumed. 
 They concluded that pregabalin premedication improved quality of 
analgesia in the early post-operative period after laparoscopic 
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gynaecological surgery. 150 mg pregabalin did not reduce the amount of 
analgesic drug. 
Sion M. Burke
29 
They evaluated patients who underwent lumbar discectomy regarding 
long term pain and the effect of pregabalin premedication on it. They 
tested the hypothesis that many patients continue to experience pain even 
3 months after discectomy. Pregabalin, a membrane stabilizer, may 
decrease perioperative central sensitization and subsequent persistent 
pain.    
 Forty patients undergoing lumbar discectomy received either placebo or 
300mg pregabalin at 90minutes pre-operatively and 150mg at 12 and 24 
hours post-operatively. Change in present pain intensity from pre-
operatively to 3 months post-operatively. 
They concluded that administration of pregabalin during peri-operative 
period was associated with less pain intensity and improved functional 
outcome 3 months after lumbar discectomy. 
P.W.H.Peng
30 
Peng evaluated the efficacy of low dose pregabalin on the analgesic 
efficacy, adverse effects, and recovery characteristics in patients 
undergoing laparoscopic cholecystectomy. 
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 He compared 50mg and 75mg of pregabalin with placebo 
administered 1hour before surgery and every 12 hours post-operatively 
for a total of 3 doses. Numeric pain score, analgesic requirement, adverse 
effects, and recovery score (QoR-40) were studied in the early post-
operative period (12hours). 
 The pain score was lesser in pregabalin75mg group in first 
90minutes after surgery and with50mg pregabalin up to 30 to 45minutes 
after surgery when compared to placebo. The analgesic requirement, side 
effects, and recovery profile were comparable between the groups. 
  They concluded that 75mg pregabalin provided limited benefits in 
the post-operative period. 
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MATERIALS AND METHODS 
 
Study design : Prospective, randomised, double blinded study 
Study population : 60 patients 
Institutional ethical committee approval obtained 
 
Inclusion criteria:  
• Age – 20 years to 60 years 
• ASA – 1 and 2, normotensive patients 
• Surgery – Elective abdominal surgery 
• Requiring general anesthesia with endotracheal tube 
• Who gives consent for the study 
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Exclusion criteria: 
• Anticipation of difficulty in airway management, and when the 
duration of laryngoscopy and intubation exceeded 30 seconds. 
• Patients with seizure disorder. 
• Uncontrolled systemic illness. 
• Patients on pregabalin or gabapentin therapy. 
• History of known allergy to pregabalin. 
• Pregnancy. 
  
Materials: 
• Pregabalin capsules.  
• Similar looking placebo capsules. 
• Patient controlled analgesia pump. 
• Pain assessment chart. 
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Primary outcome measures: 
• Ramsay sedation scale. 
• Heart rate, systolic, diastolic, mean blood pressure at baseline, 1, 3, 
5, 10, 15minutes after laryngoscopy and intubation. 
• Recovery characteristics from general anesthesia. 
 
Secondary outcome measures: 
• Post-operative fentanyl requirement. 
• Any adverse effects to pregabalin.    
Study protocol: 
1. All the patients were visited the evening before surgery. They were 
explained about the study methods, the visual analogue scale chart, 
methods to use patient controlled analgesic pump, and were provided 
with information sheet. 
2. Only those who gave consent for the study and satisfied inclusion 
criteria were included. The night before surgery patients received 
Ranitidine 150 mg and Alprazolam 0.5 mg per oral. 
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3. Randomisation – sixty patients were allocated randomly into two 
groups of 30 each. Group-C received placebo capsules and Group-P 
received 150 mg pregabalin, one hour before induction. Both the 
investigator and the observer were not aware of the groups till the end 
of the study. 
4. The morning of surgery, patients received Ranitidine 50 mg and 
Metoclopramide 10 mg, intravenously, and the test drug was given 
orally with  
sips of water, one hour before induction. Both the group allocation and 
administration of test drug were done by an anesthetist who was not 
involved in the study. 
 
5. Sedation level – The level of sedation was recorded prior to test 
drug administration, one hour later, and prior to premedication. At 
post anesthesia care unit (PACU), sedation level was assessed at 
baseline, 1hour, 2hours, 4hours, 8hours, and at 12hours after 
surgery. 
 
 
 
  
43 
Table-2: Ramsay sedation scale 
 Patient anxious and agitated or restless, or both 
 Patient co-operative, oriented, and tranquil 
 Patient responds to commands only  
 Sedated with brisk response to stimulus 
 Sedated with sluggish response to stimulus 
 Sedated with no response to stimulus 
 
(Stimulus – light glabellar tap or loud command at ears) 
 
6. Heart rate, systolic, diastolic, and mean blood pressure were 
recorded at baseline on arriving to operating table, after premedication, 
after induction, 1 minute, 3 minutes, 5 minutes, and 10 minutes after 
laryngoscopy and intubation. Bradycardia defined as heart rate less than 
60 per minute, was treated with Atropine 0.6 mg intravenously. 
Hypotension defined as systolic blood pressure less than 90 mmHg, 
was treated 200 ml bolus infusion of crystalloid solution and Ephedrine 
3 mg, intravenously.  
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7. Laryngoscopy and intubation was performed by an anesthetist who 
had not less than 2 years of experience in laryngoscopy. Duration taken 
to do laryngoscopy and intubation, and the grade of laryngoscopic view 
were recorded. When the duration exceeded 30 seconds, the case was 
excluded from the study. 
8. The characteristics of recovery from general anesthesia, and the 
occurrence of nausea, vomiting, shivering, bradycardia (heart rate less 
than 60/minute), hypotension (systolic blood pressure less than 
80mmHg), and respiratory depression (defined as 
respiratory<10/minute, SpO2<90%) were documented. 
9.  All the patients were shifted to post anesthesia care unit (PACU)  
10.  Pain relief was provided with intravenous patient controlled 
analgesia with fentanyl. 
   Anesthetic management: 
Surgery was done under general anesthesia with endotracheal tube and 
controlled ventilation. Ringer lactate was started at 100 ml/hour 
through 18G intravenous cannula. Heart rate, SP02, non-invasive blood 
pressure, electrocardiographic monitoring was done.  
Pre-medication was done with glycopyrrolate 0.2 mg, midazolam 0.04 
mg/kg, and fentanyl 2mcg/kg intravenously, 5 minutes before 
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induction. Induced with thiopentone 5mg/kg i.v and intubation 
facilitated by succinylcholine 1.5mg/kg. 
Anesthesia was maintained with 2% sevoflurane, in a mixture of 66% 
nitrous oxide in oxygen. Ventilation controlled with closed circuit, 
facilitated by increments of 0.02mg/kg vecuronium. Vital signs were 
monitored every 5 minutes during intra-operative period and 
intravascular volume replacement was done appropriately. At the end 
of the procedure residual neuro muscular blockade was reversed with 
neostigmine 50mcg/kg with glycopyrrolate 0.5mg. After complete 
recovery, extubation was done. 
 
 Post-operative management: 
On arrival to PACU, all the patients were offered patient controlled 
analgesia with intravenous fentanyl. Heart rate, blood pressure, and 
SPO2 were monitored. Level of sedation was assessed with Ramsay 
sedation scale, and the magnitude of pain was assessed with 10 points 
visual analogue scale periodically at baseline, 1 hour, 2hours, 4 hours, 8 
hours, and 12 hours after surgery.  
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A separate i.v access was used for PCA pump. Hemodynamic 
parameters  were recorded regularly and oxygen saturation monitored. 
Patients were observed for any adverse effects of fentanyl, proper 
functioning of PCA pump, break through pain, and the need for 
additional doses of fentanyl.   
PCA protocol:  
• Drug   - Fentanyl 
• Concentration - 10 microgram/ml 
• Basal infusion - Nil 
• Demand dose - 2.5ml (25mcg) 
• Lock-out interval - 15 minutes 
Whenever the patient had VAS of 4 or more, an additional dose of 
25mcg of fentanyl was given intravenously. The fentanyl requirement 
for the first 12 hours of surgery was documented. The total requirement 
over 12 hours was calculated by adding total demand doses and 
additional doses made. The frequency of additional dose requirement 
was also compared between the two groups. 
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Study population size and statistical analysis: 
 Statistician was consulted with pilot study report of 5 cases in each 
group. The hypothesis testing of two means showed the sample size 
needed was 13, for the power of study to be 0.8 with alpha error of 5. 
Considering the number of patients who drop out from the study, the 
sample size was fixed at 30 in each group. 
 The statistical analysis was done using SPSS software, version 12. 
The mean and standard deviation calculated using student T test, and 
the significance calculated by chi-square test. P-value less than 0.05 
was taken as significant, and less than 0.01 as highly significant. 
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RESULTS 
 
The study was done in 60 patients of both sexes in the age group of 20 to 
60 years, belonging to ASA class-1 and ASA class-2, undergoing elective 
abdominal surgery under general anesthesia with endotracheal tube. The 
patients were categorised into two groups. 
 Group-C - Placebo 
 Group-P - pregabalin 
Statistical analysis 
 We did statistical analysis of the data collected using Microsoft 
Excel, and SPSS software. Student t-test and Chi-square test were used as 
appropriate. P value less than 0.005 was taken as significant and value 
less than 0.001 was taken as highly significant. 
Demographic profiles 
 The demographic profiles like age, sex, and weight, and the ASA status, 
are comparable between the two groups (Table-1). No statistical 
significance is found when comparing these factors between the two 
groups. 
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Table-1: Demographic profiles, and ASA status 
Demographic profile Group-C GROUP-P p-value 
Age (years) 37.87 ± 6.75 34.70 ± 8.36 0.112 
Sex (M:F) 13:17 12:18 1.000 
Weight (Kg) 59.80 ± 5.93 59.00 ± 9.09 0.688 
ASA class 1: 2 , (n) 20:10 20:10 1.000 
 
Fig-5 : Comparison of demographic data 
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Fig- 6: Comparison of demographic data 
 
 
 
Fig-7: Comparison of demographic data 
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Nature and duration of surgery 
The types of surgery are equally distributed among the two groups 
(Table-2). The mean duration of surgery is comparable. There is no 
statistically significant difference in these factors. In both control group 
and pregabalin group, the mean duration of laryngoscopy are comparable. 
 
Table-2: Nature, and duration of surgery 
 Group-C Group-P 
Open cholecystectomy, number (%) 6 (20.0%) 7 (23.3%) 
Incisional hernia 7 (20.0%) 6 (23.3%) 
Open appendicectomy 7 (23.3%) 6 (20.0%) 
Paraumblical hernia repair 3 (10.0%) 3 (10.0%) 
Abdominal hysterectomy 3 (10.0%) 4 (13.3%) 
Epigastric hernia repair 4 (13.3%) 4 (13.3%) 
Duration of surgery, mean(minutes) 90.07 92.33 
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Baseline parameters 
Baseline hemodynamic parameters are comparable between the two 
groups. There is no statistically significant difference between the groups. 
Table-3: Baseline hemodynamic parameters in mean±SD 
Parameter  Group-C Group-P p-value 
Heart rate 74.90±4.49 73.87±6.51 0.479 
Systolic blood 
pressure 
123.27±8.294 122.10±8.294 0.639 
Diastolic blood 
pressure 
77.50±6.157 77.90±5.573 0.793 
Mean blood pressure 92.53±7.417 92.30±5.754 0.892 
  
Fig-8: Comparison of baseline hemodynamic parameters 
 
 
0 
20 
40 
60 
80 
100 
120 
140 
HR SBP DBP MAP 
Group-C 
Group-P 
  
53 
Heart rate changes: 
There was no significant difference in heart rate at baseline, before and 
after induction. In both the groups, heart rate raised at 1minute, 3minutes, 
and 5minutes following laryngoscopy and intubation. The raise in heart 
rate is significantly less in pregabalin group when compared to control 
group. The raise in heart rate normalised 5 minutes after laryngoscopy 
and intubation in both the groups (Table-3).  
Table-4: Heart rate changes during anesthesia (mean±SD) 
 Group-C Group-P p-value 
After premedication 80.10 ± 5.59 79.33 ± 7.10 0.644 
After induction 82.03 ± 5.26 81.73 ± 5.28 0.826 
After intubation 
(0min) 
95.17 ± 7.83 89.07 ± 6.98 0.002 (#) 
1 minute 96.87 ± 8.45 91.43 ± 8.55 0.016 (#) 
3 minutes 87.10 ± 8.47 81.87 ± 8.21 0.018 (#) 
5 minutes 80.87 ± 8.24 77.30 ± 7.23 0.080 
# - p-value highly significant  
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Deviation of heart rate from baseline 
 
Fig-9: Heart rate changes in mean±SD 
  
AP-after premedication, AI-after induction, 0minute, 1minute, 3minutes, 
and 5minutes after laryngoscopy and intubation. 
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Deviation of blood pressure from baseline 
There was no significant difference in systolic, diastolic, and mean 
blood pressure at baseline, before and after induction. But there was 
statistically significant attenuation of systolic and diastolic blood pressure 
in pregabalin group at o minute, 1 minute, and 3 minutes after intubation. 
The attenuation of mean blood pressure was highly significant in 
pregabalin group, when compared to the control group. 
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Table-5: Systolic blood pressure changes in mmHg (mean±SD) 
 Group-C Group-P p-value 
After premedication 120.53±8.565 118.80±8.058 0.423 
After induction 115.13±11.617 111.57±10.295 0.213 
After intubation 
(0min) 
147.50±20.080 131.13±15.976 0.001 (#)  
1 minute 151.37±21.787 134.47±16.137 0.001 (#) 
3 minutes 129.13±15.741 117.13±16.126 0.005 (#) 
5 minutes 122.23±12.894 117.80±11.090 0.159 
# - p-value highly significant 
Fig-10: systolic blood pressure changes 
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Table-6: Diastolic blood pressure changes in mmHg (mean±SD) 
 Group-C Group-P p-value 
After premedication 75.90±6.157 77.07±5.552 0.478 
After induction 72.87±7.855 70.03±5.623 0.114 
After intubation 
(0min) 
97.00±14.648 87.67±11.137 0.007 (#) 
1 minute 98.90±14.033 90.50±10.979 0.012 (#) 
3 minutes 83.87±10.275 76.23±11.413 0.009 (#) 
5 minutes 81.00±9.248 77.33±6.999 0.089 
# - p-value highly significant 
Fig-11: changes in diastolic blood pressure 
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Table-7: Mean blood pressure changes in mmHg (mean±SD) 
 Group-C Group-P p-value 
After premedication 90.03±7.275 90.67±5.933 0.713 
After induction 86.53±8.936 83.43±6.290 0.126 
After intubation 
(0min) 
113.57±15.822 101.97±12.339 0.002 (#)
 
1 minute 116.63±17.553 104.77±12.414 0.004 (#) 
3 minutes 98.33±11.778 89.33±12.788 0.006 (#) 
5 minutes 94.23±10.037 90.07±8.026 0.081 
# - p-value highly significant  
Fig-12: Changes in mean blood pressure 
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Ramsay sedation scale and duration of intubation: 
The mean duration of laryngoscopy and intubation in Group-C was 
comparable with that in Group-P. The patients in pregabalin group were 
sedated with brisk response to stimulus. The mean Ramsay sedation scale 
in Group-P before evaluated 1 hour after pre5gabalin administration was 
higher when compared to Group-C, with high statistical significance 
(Table-7). 
 
Table-8: RSS after 1hour, and duration of laryngoscopy and 
intubation 
 Group-C Group-P p-value 
RSS (mean±SD) 2.00±0.00 3.17±0.699 0.000 
Laryngoscopy (seconds) 10.10±1.989 10.10±1.749 1.000  
(RSS – Ramsay sedation scale) 
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Visual analogue scale for pain at rest: 
The mean visual analogue scale (VAS) for pain at rest evaluated at 
baseline, 1hour, 4hours, 8hours of receiving patients at PACU, were 
comparable between the two groups, except at 2hours, and 12hours when 
Group-P had significant less VAS for pain at rest (Table-8). 
 
Table-9: Visual analogue scale for pain at rest 
VAS (mean±SD) Group-C Group-P p-value 
Baseline 6.67±1.061 6.43±1.194 0.427 
1 hour 3.77±1.194 3.17±1.262 0.064 
2 hours 2.90±0.548 2.57±0.626 0.032 
4 hours 3.47±1.279 2.90±0.995 0.060 
8 hours 3.33±0.959 2.87±0.937 0.062 
12 hours 2.70±0.535 2.33±0.479 0.007 
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Post-operative sedation level: 
The patients in pregabalin group were more sedated than that in control 
group, especially in the first two hours of post-operative period. They 
responded briskly to stimulus. The sedation level did not interfere in 
evaluating the Visual analogue scale for pain. The median Ramsay 
sedation scale were ………….. at baseline, 1hour, and 2hours 
respectively, and the difference in sedation level was highly significant 
between the groups. 
Table-10: Sedation level at PACU 
RSS at PACU Group-C Group-P p-value 
Baseline 1.70±0.466 2.87±0.681 0.000 (#) 
1 hour 2.07±0.254 3.40±0.675 0.000 (#) 
2 hours 2.30±0.466 3.43±0.568 0.000 (#) 
4 hours 2.60±0.536 2.83±0.747 0.177 
8 hours 2.37±0.490 2.37±0.490 1.000 
12 hours 2.23±0.430 2.30±0.466 0.567 
# - p-value highly significant  
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Adverse effects related to pregabalin and fentanyl:  
 
The mean time to recovery of the patients from general anesthesia, 
for the return of response to simple verbal commands after last skin 
suturing was 11.4 minutes in control group and 12 minutes in pregabalin 
group. There was no delay in recovery in pregabalin group, the difference 
was statistically not significant. The incidence of nausea and vomiting 
was similar in both the groups. There was no incidence of bradycardia, 
hypotension, pruritis, and respiratory depression in both the groups. None 
of the patients in both groups had these adverse effects. 
 
 
 
 
 
 
 
 
  
63 
Table-11: Pregabalin and fentanyl related adverse effects 
Events  Group-C Group-P p-value 
Time to recovery 
(minutes) (mean±SD) 
11.40±1.545 12.00±1.486 0.131 
Nausea, vomiting, n (%) 19(63.3%) 19(63.3%) 1.000 
Bradycardia (n) 0 0 - 
Hypotension (n) 0 0 - 
Respiratory depression 
(n) 
0 0 - 
Pruritis (n) 0 0 - 
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Post-operative PCA fentanyl requirement: 
Additional fentanyl doses:  
Apart from patient controlled fentanyl, 26 patients (86.7%) out of 
30 in pregabalin group did not require any additional bolus doses of 
fentanyl, and 4 patients (13.3%) needed 1 additional dose. In control 
group, out of 30 patients, 13 patients (43.3%) required 1 additional dose, 
1 patient (3.3%) required 2 additional doses, and 16 patients (53.3%) 
required no additional doses. The additional fentanyl requirement was 
significantly less in pregabalin group with p-value of 0.012 (Fig-1). 
 
Total fentanyl requirement in first 12 hours: 
 When compared to group-C, group-P had highly significant less 
requirement of fentanyl during the post-operative period. The total of 
loading dose, demand doses, and additional doses of fentanyl was 317 
microgram in control group, and it was 204 microgram in pregabalin 
group over first 12 hours after surgery. This reduced fentanyl requirement 
in pregabalin group had high statistical significance, with p-value of 
0.000 (Fig-2). 
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Fig-13: Number of additional doses of fentanyl 
 
 
Fig-14: Total fentanyl requirement in micrograms 
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DISCUSSION 
 
This study evaluated the effectiveness of premedication with a single 
dose of pregabalin administered orally one hour before induction on 
attenuation of hemodynamic stress response to laryngoscopy and 
intubation. The possibility of preemptive effect of pregabalin on post-
operative patient controlled fentanyl requirement was also evaluated. 
Pregabalin premedication produced useful pre-operative sedation which 
did not prolong the recovery time from general anesthesia. The post-
operative patient controlled fentanyl requirement was significantly 
reduced. Pregabalin did not produce cardiovascular side effects like 
bradycardia or hypotension. There was no respiratory depression or 
pruritis. However patients remained sedated for first 2 hours in PACU 
with brisk response to verbal commands. 
 Laryngoscopy and tracheal intubation elicits transient but harmful 
hemodynamic stress response. Tachycardia and hypertension are frequent 
complications during laryngoscopy and intubation, which occurs due to 
reflex sympathoadrenal response. Increase in serum catecholamines 
concomitant with laryngoscopy and the observations that beta receptor 
blockade attenuated the pressor response further confirmed the reflex 
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sympathoadrenal response as a possible mechanism for the stress 
response.
31
 
This hemodynamic response is associated with increased incidence of 
myocardial ischemia, infarction, and dysrhythmias. Hypertensive patients 
and elderly people have exaggerated response and consequent increase in 
morbidity and mortality. Hence, this pressor response has to be attenuated 
by some pharmacological techniques.
19
 
Intravenous lignocaine in a dose of 1.5 mg/kg given 90 seconds 
before induction attenuated pressor response but failed to attenuate 
tachycardia. Fentanyl 0.5 to 1 mcg/kg or remifentanyl 1 mcg/kg reduced 
pressor response but has the disadvantage of occurrence of bradycardia. 
More recently remifentanil has been studied and found to have attenuated 
pressor response but was associated with bradycardia in patient who have 
not received glycopyrrolate, and occurrence of hypotension.
32
 
Gabapentin is a gabapentenoid drug with anticonvulsant, sedative, 
anxiolytic and analgesic properties. Gabapentin had been studied on 
attenuation of laryngoscopic pressor response and its effect on opioid 
sparing. Fassoulaki administered total of 1600mg gabapentin as a serial 
of four doses and found to attenuate pressor response but not tachycardia 
with intubation.  
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 Both gabapentin and pregabalin has similar chemical structure and 
both acts on alpha 2 delta subunit of neuronal calcium channels. But 
pregabalin has better pharmacological profiles than gabapentin in that 
pregabalin has predictable onset time with peak effect in 1 hour and 
>90% oral bioavailability. In their study Sundar et al concluded that 
150mg pregabalin attenuated reflex tachycardia and hypertension related 
to laryngoscopy and intubation which in concurrence with our study.
25
  
The dose of pregabalin preferred in this study was based on a dose   
ranging study done by Paul F. White et al, in which 75mg, 150mg, and 
300mg dose of pregabalin were compared. They found excessive sedation 
with 300mg dose. Further, Rastogi Bhawna et al in their study found 
75mg pregabalin did not effectively attenuate the pressor response.
3 
 
P.W.H.Peng postulated that multiple small doses of pregabalin could 
reduce post-operative opioid requirement. He found multiple doses of 
75mg pregabalin reduced pain scores with limited benefits in the first 90 
minutes after surgery. Analgesic requirement was the same.
30 
Based on these studies the optimal dose of pregabalin was decided 
to be 150mg which could attenuate pressor response without excessive 
perioperative sedation. 
 When studying the efficacy of a drug to attenuate laryngoscopic 
pressor response, the anesthetic technique employed affects the result of 
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the study. In this present study tachycardia occurred in both the groups, 
but the magnitude of increase was less with pregabalin premedication. 
This result is in contradiction to that of Fassoulaki who observed no 
difference in heart rate with gabapentin.
22
    
This difference in result could be because of the anesthetic technique, 
where they induced with propofol which tend to cause bradycardia 
masking the effect of gabapentin on heart rate. In our study, both the 
thiopentone induced and succinylcholine fasciculation induced 
tachycardia could have resulted in tachycardic response in both the 
groups. But the increase in heart rate was less in pregabalin premedicated 
patients. 
The exact mechanism of attenuation of pressor response by 
pregabalin is not known. The blocking of neuronal calcium channels 
could be the possible mechanism that it may act in a similar manner by 
which calcium channel blockers controls the hemodynamic response. 
Primary culture of bovine adrenal chromaffin cells was used by Robert D 
Todd to study the effects of gabapentin on adrenal cells. He observed that 
gabapentin reduced release of catecholamine from adrenal chromaffin 
cells without altering its contents. Gabapentin did not restrict the entry of 
calcium into cells but calcium was less effective in causing vesicle 
fusion.
33 
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The duration of laryngoscopy, grade of laryngeal view can affect 
the result of the study. In this study the laryngoscopy was done by 
anesthesiologist who had at least two years of experience. When the time 
taken to do laryngoscopy and tracheal intubation exceeded 30 seconds, 
patients were withdrawn from the study. The grade of laryngeal view and 
duration of laryngoscopy were comparable between the two groups.   
Induction of general anesthesia was done in this study with thiopentone 
sodium which can cause tachycardia and the fasciculation caused by 
succinylcholine can also increase heart rate. This could have masked the 
effect of pregabalin on heart rate. Though the magnitude of tachycardia 
was less in pregabalin group, both the groups had increase in heart rate 
from the baseline value.  
 The level of pre-operative sedation was significantly higher with 
pregabalin premedication which did not prolong the recovery process 
from general anesthesia. This can be an advantage in the pre-operative 
period, but preanesthetic sedation can interfere with the randomisation of 
groups. 
 Evaluation of anxiety level, measurement of serum catecholamine 
level, observation of intra-operative fentanyl requirement would have 
provided more information. This was not done in this present study.  
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In this study, patient controlled analgesia with intravenous fentanyl 
was used for post-operative pain relief. This technique helped in 
estimating the fentanyl requirement accurately than using intermittent 
bolus doses. Non-steroidal anti-inflammatory drug was not given in this 
case. The visual analogue scale for pain at rest was comparable with 
placebo group, which points out to no improvement in the quality of 
analgesia with pregabalin premedication. This finding is in contradiction 
with the observation made by Jokela.R and colleagues that VAS score 
was lesser in patients who received 150mg pregabalin with 800mg 
Ibubrufen, which indicates better quality of analgesia.
28
  
This difference could be because of difference in the rescue analgesic 
method used. With multimodal analgesia the quality of pain relief could 
have been better in this study. 
 The pregabalin premedicated patients required 4 additional doses 
and a total of 204 microgram of fentanyl. Whereas placebo group 
required 14 additional doses and a total of 317 microgram of fentanyl 
over the first 12 hours after surgery. None of the patients in both groups 
had bradycardia, hypotension, respiratory depression, or pruritis.  
 Mathieson concluded that 300mg pregabalin reduced post-
operative morphine requirement by 50% but with greater sedation, nausea 
and vomiting.
27
 Whereas in our study 150mg pregabalin produced 
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fentanyl sparing effect without any adverse effects. This opioid sparing 
effect of pregabalin is because of alpha 2 delta receptor blockade induced 
reduction in release of several excitatory aminoacids. This blocks the 
central sensitisation process caused by the surgical incision induced 
activation of peripheral nociceptors. Hence, pregabalin produces an 
antihyperalgesic effect. 
Pregabalin is a drug with good safety profile. It is not metabolised, 
do not interfere with microsomal p450 enzymes, and not protein bound. 
All these properties explain the lack of pharmacological drug interactions. 
Pregabalin acts on N-type calcium channels, whereas myocardium and 
other peripheral tissues have L-type calcium channels
6
. The lack of action 
on cardiac type calcium channels explains the absence of cardiovascular 
system related side effects. The commonest side effects of pregabalin are 
drowsiness and somnolence. Pregabalin lacks GABAnergic activity 
which explains the lack of retinal or optic nerve toxicity.
7 
Pregabalin has got the novel mechanism of action on alpha 2 delta 
subunit of neuronal calcium channels which helps in blunting the release 
of excitatory neuro aminoacids. Although the exact mechanism of 
attenuation of hemodynamic response to laryngoscopy and intubation by 
pregabalin is not known, this must be because of calcium channel 
blocking caused by pregabalin. Gabapentin reduced catecholamine 
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release from adrenal chromaffin cells.
33
 Calcium channels are not 
completely blocked to the influx of calcium, but the calcium is not able to 
facilitate vesicular fusion. 
 In the method done, this study observed that premedication with 
150mg pregabalin an hour before induction as a single dose attenuated 
hemodynamic response to laryngoscopy and tracheal intubation. It 
produced pre-operative sedation without prolonging the recovery from 
general anesthesia in patients undergoing abdominal surgery. Pre-
operative pregabalin 150mg reduced patient controlled fentanyl 
requirement in the first 12hours after surgery. 
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SUMMARY 
This prospective, randomised, double blinded, and placebo 
controlled study evaluated the efficacy of single oral dose of 
150mg pregabalin given an hour before induction on attenuation 
of hemodynamic response to laryngoscopy and tracheal 
intubation. 
 Sixty ASA1 and 2 patients of 20 to 60 years age group of 
both sexes undergoing abdominal surgery were randomised into 
two groups 
 Group-C – placebo 
 Group-P – 150mg pregabalin 
General anesthetic techniques were standardised. Sedation scale prior to 
induction was documented. Heart rate, systolic, diastolic, and mean blood 
pressure were recorded at baseline and at 1minute, 3minutes, and 
5minutes after laryngoscopy and intubation. Duration of laryngoscopy, 
grading of laryngeal view, and time to recovery of response to simple oral 
commands were recorded. Post-operatively pain relief was provided 
through intravenous patient controlled fentanyl at a demand dose of 
25mcg. Pain was assessed with numeric pain scale. Whenever the patient 
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gets pain score of more than 4, an additional dose of 25mcg of fentanyl 
was administered 
Results were tabulated and statistical analysis was done using Microsoft 
excel, and SPSS software. Student t-test was used for quantitative 
variables and chi-square test for qualitative variables. With the patients 
matched for demographic profiles, the results showed that there was no 
significant difference in baseline hemodynamic variables between the two 
groups. 
 Pregabalin group patients remained sedated pre-operatively. There 
was significantly less elevation in blood pressure following laryngoscopy 
and intubation in pregabalin group. Although tachycardia occurred in 
both groups following intubation, the raise heart rate was significantly 
less in pregabalin group. There was no difference in recovery time. 
 Post-operative pain scores were comparable between the groups. 
Patients in pregabalin group required significantly less additional doses 
and total dose of patient controlled fentanyl over 12 hours after surgery. 
 There was no difference in the incidence of nausea and vomiting 
between the groups. None of the patients in both groups had bradycardia, 
hypotension, pruritis, or respiratory depression. 
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CONCLUSION   
Premedication with 150mg of pregabalin an hour before induction 
causes significant attenuation of hemodynamic response to tracheal 
intubation and reduces post-operative fentanyl requirement without any 
side effects in patients undergoing abdominal surgery. 
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HR-
IL5 SBP-BL
SBP-
AP SBP-AI
SBP-
IL0 SBP-IL1 SBP-IL3
SBP-
IL5
DBP-
BL DBP-AP DBP-AI
DBP-
IL0
DBP-
IL1
DBP-
IL3
DBP-
IL5
1 saranraj 34 1 54 1 1 1 1 105 3 84 89 89 93 102 81 82 136 119 128 139 147 125 119 78 76 74 91 93 70 69
2 fathima 36 2 62 2 2 1 1 90 3 76 84 86 90 90 79 72 140 122 99 106 109 97 112 77 83 62 67 72 62 74
3 sumathi 40 2 58 2 2 1 1 85 4 68 74 72 81 83 71 72 117 103 95 114 122 135 136 83 67 66 81 83 96 94
4 mumtaz 35 2 54 1 1 2 1 115 3 70 82 84 88 88 77 73 110 110 107 117 121 94 93 76 74 77 90 91 65 66
5 palani 34 1 62 4 4 1 1 85 3 86 92 91 93 93 88 89 129 129 130 146 152 112 118 91 90 85 97 101 72 81
6 durai 27 1 60 3 3 1 1 75 3 78 82 80 86 88 76 78 124 114 101 142 148 107 109 80 74 68 103 107 74 76
7 nagendran 35 1 58 1 1 2 1 100 4 76 82 80 86 84 78 74 119 117 113 125 125 91 115 77 75 72 76 79 48 83
8 ellammal 34 2 56 3 3 1 1 70 3 76 86 84 89 92 80 76 114 112 100 148 156 110 101 75 76 65 99 108 81 67
9 saradha 45 2 60 5 5 1 1 110 4 86 92 94 108 112 96 88 123 122 111 159 164 159 133 86 86 75 104 107 102 93
10 manonmani 45 2 58 2 2 1 1 80 4 84 94 89 94 92 94 92 116 109 101 126 124 121 117 74 72 63 86 83 68 72
11 mary 42 2 64 2 2 2 1 90 2 76 81 84 89 93 86 88 132 132 127 138 136 112 114 80 82 76 94 96 79 76
12 lakshmi 36 2 64 6 6 2 1 100 2 70 76 79 86 88 77 74 122 116 99 126 126 101 103 82 74 68 93 94 79 78
13 anbazhagan 48 1 70 4 4 1 1 65 3 60 64 72 90 92 78 62 126 129 120 132 147 131 141 84 84 70 92 96 92 88
14 ghandhi 45 2 60 2 2 1 1 110 2 74 79 82 86 86 88 86 130 128 123 148 148 124 119 80 79 63 92 95 80 78
15 selvam 34 1 70 1 1 1 1 90 2 73 78 82 85 85 70 72 130 133 124 151 147 127 124 78 78 74 96 98 84 82
16 prema 41 2 64 6 6 1 1 80 3 74 80 86 90 92 74 76 124 121 118 127 134 110 112 78 76 74 86 89 71 74
17 arulmozhi 29 2 56 3 3 2 1 70 4 68 71 76 79 82 74 76 108 110 103 110 114 101 108 70 68 67 74 78 68 70
18 senthilkumar 32 1 80 1 1 1 1 105 2 76 74 78 80 80 75 76 110 110 108 114 119 102 101 76 72 72 65 78 73 68
19 mary 30 2 54 3 3 1 1 75 4 71 76 80 94 94 96 81 121 112 111 126 128 114 120 78 78 73 90 90 78 76
20 bhaskar 27 1 60 3 3 1 1 60 3 78 82 87 95 97 84 80 129 126 121 138 136 118 126 84 82 72 93 94 74 76
21 lakshmi 42 2 58 6 6 2 1 115 3 64 71 76 82 84 79 71 130 128 118 133 142 110 114 82 84 71 94 92 68 74
22 jothi 44 2 56 5 5 1 1 120 4 70 75 79 83 91 78 69 126 128 119 128 132 129 118 84 84 78 86 88 84 80
23 kannan 31 1 58 1 1 1 1 110 3 68 79 82 97 106 95 88 122 118 121 165 158 149 132 81 77 70 101 103 90 81
24 ravi 42 1 63 1 1 2 1 90 3 71 78 81 89 95 83 74 116 112 108 129 127 102 110 68 71 64 84 90 58 72
25 kalarani 37 2 57 5 5 1 1 115 4 80 88 82 96 103 90 75 112 116 102 108 107 117 121 71 74 61 67 69 73 72
26 venugopal 50 1 58 6 6 2 1 90 4 65 71 78 86 85 73 71 120 110 98 125 132 121 126 74 77 65 95 101 82 82
27 eswaran 43 1 58 2 2 1 1 100 3 82 79 86 107 113 99 87 132 129 120 159 167 148 136 81 82 76 102 105 92 84
28 selvi 40 2 60 5 5 2 1 120 3 71 77 80 84 87 87 73 113 117 100 123 128 116 118 69 71 65 84 84 72 76
29 pratheba 28 2 52 3 3 1 1 60 4 72 71 75 81 81 74 71 120 118 112 124 126 117 118 70 72 70 78 79 72 74
30 kalimuthu 50 1 50 4 4 2 1 90 3 69 73 78 85 85 76 73 112 114 110 108 112 114 120 70 74 65 70 72 80 84
31 sheela 29 2 76 1 1 1 2 100 2 72 83 84 88 95 88 82 116 116 120 139 142 118 116 68 76 77 99 101 82 76
32 saroja 38 2 58 1 1 1 2 90 2 72 80 82 90 91 82 76 140 132 142 133 134 119 109 86 80 87 74 78 67 72
33 manoharan 38 1 62 1 1 1 2 115 2 80 86 92 106 102 102 98 136 123 124 148 162 131 116 88 86 86 108 120 96 81
34 vasu 30 1 62 3 3 1 2 80 2 78 92 92 98 96 88 82 134 121 117 186 199 149 117 81 66 75 108 115 92 81
35 rajamalar 26 2 45 3 3 1 2 75 2 74 79 84 91 92 81 76 110 110 95 142 133 125 122 70 77 65 102 103 95 89
36 savithri 36 2 55 1 1 1 2 110 2 86 92 89 101 108 92 80 126 122 119 158 162 135 126 80 88 77 113 116 98 86
37 nareshkumar 21 1 56 3 3 1 2 56 2 71 74 79 89 88 72 74 120 118 116 121 128 112 116 78 71 76 82 86 71 70
38 vasanthi 40 2 52 5 5 2 2 95 2 70 74 79 89 94 71 76 124 122 116 139 142 128 118 82 82 74 89 98 84 78
39 shakila 39 2 63 5 5 2 2 110 2 76 78 82 86 88 86 82 110 99 90 101 102 101 92 71 62 54 68 69 66 63
40 padmavathi 26 2 55 1 1 1 2 120 2 76 78 74 96 94 86 92 124 117 112 139 144 124 152 83 69 70 82 80 78 113
41 chinapillai 47 2 42 2 2 2 2 105 2 78 82 74 104 102 108 107 116 123 102 152 147 124 102 73 79 80 94 98 88 72
42 pothammal 45 2 60 6 6 1 2 90 2 76 84 86 102 98 88 80 141 139 139 162 165 152 132 88 90 89 106 107 100 92
43 manikandan 41 1 74 4 4 1 2 75 2 71 75 79 84 82 86 80 126 128 122 187 190 146 138 82 81 80 132 123 85 82
44 karthik 22 1 54 3 3 1 2 70 2 76 82 86 108 112 92 81 109 112 110 153 160 136 125 78 78 74 125 122 92 91
45 devamani 40 2 72 2 2 2 2 95 2 81 86 86 92 92 84 81 132 130 118 149 157 142 136 80 81 76 98 95 84 78
46 anusuya 22 2 57 3 3 1 2 90 2 69 73 78 88 86 75 71 112 113 108 142 139 118 110 70 70 62 86 92 76 74
47 gopal 40 1 55 2 2 1 2 85 2 70 76 79 106 110 95 88 126 121 120 163 165 142 131 84 82 78 100 104 86 80
48 radha 41 2 58 2 2 1 2 96 2 73 71 83 89 95 87 70 112 114 108 133 138 117 112 70 68 71 84 86 69 70
49 mekala 35 2 65 6 6 2 2 100 2 79 85 86 99 99 82 74 120 121 112 162 171 141 118 70 70 62 109 108 87 79
50 amudha 21 2 54 3 3 1 2 70 2 68 74 75 89 92 84 76 106 111 102 105 109 111 118 71 69 65 79 80 77 81
51 shanthi 39 2 48 2 2 2 2 80 2 76 82 86 90 96 85 71 132 129 99 157 163 131 141 78 74 63 99 102 87 90
52 arumugam 41 1 56 4 4 2 2 75 2 82 84 81 105 109 98 87 140 118 110 152 165 111 121 82 71 69 94 92 74 78
53 rajan 36 1 60 2 2 1 2 90 2 75 79 78 99 110 92 86 142 138 127 171 169 158 131 84 84 80 105 106 92 87
54 rafiq 27 1 81 1 1 1 2 95 2 71 75 80 112 112 98 89 118 118 116 159 167 139 127 72 71 72 110 111 94 86
55 kumaran 42 1 62 6 6 2 2 100 2 78 84 88 96 101 89 77 128 126 130 148 151 119 121 82 82 76 93 96 78 83
56 prabakaran 28 1 70 4 4 1 2 85 2 70 73 73 90 93 88 72 112 114 109 132 131 111 112 71 72 68 89 90 73 78
57 deepa 21 2 56 3 3 1 2 70 2 71 78 79 88 87 76 74 110 112 108 138 138 119 116 71 70 69 86 89 78 72
58 vasantha 40 2 52 5 5 2 2 110 2 70 74 75 83 84 76 77 120 122 116 123 126 108 112 72 70 68 82 82 71 76
59 santhosam 48 2 46 2 2 2 2 90 2 78 84 88 96 97 88 81 126 118 121 159 167 151 137 78 76 72 101 105 98 86
60 velu 42 1 64 6 6 1 2 80 2 80 86 84 101 101 94 86 130 129 126 172 175 156 143 82 82 71 113 113 98 86
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95 96 90 114 114 98 96 8 4 3 3 4 2 8 6 4 4 6 3 2 2 3 3 2 2 0 0 0 0 0 9 250 0 8 12
93 91 88 99 104 84 86 6 3 2 3 2 2 7 4 4 3 3 3 3 4 4 4 3 2 1 0 0 0 0 5 150 0 8 14
82 82 79 86 90 79 82 4 2 2 4 3 3 6 4 3 4 3 3 3 4 4 3 2 2 1 0 0 0 0 5 150 0 10 10
87 84 84 81 91 82 79 8 4 3 3 3 3 8 6 6 4 4 4 2 3 3 2 2 3 0 0 0 0 0 10 275 0 12 12
92 89 85 102 102 90 90 6 3 3 3 4 3 8 4 6 4 4 4 3 4 4 4 2 3 0 0 0 0 0 6 175 0 10 12
99 96 88 108 108 88 92 8 5 3 3 4 2 8 8 4 4 5 4 2 3 3 2 2 3 1 0 0 0 0 9 250 0 8 14
98 98 86 107 108 82 87 6 3 3 3 4 3 6 4 4 5 5 4 3 4 4 3 2 2 1 0 0 0 0 11 300 0 8 10
98 98 91 100 102 99 92 6 3 4 3 3 3 8 4 4 5 4 4 4 4 4 3 3 2 1 0 0 0 0 7 200 0 13 12
94 90 87 122 121 109 98 7 4 3 3 3 3 8 5 4 4 4 4 3 3 3 2 2 3 0 0 0 0 0 10 275 0 12 13
84 84 78 99 102 72 84 6 3 3 5 3 2 6 4 4 7 4 3 3 3 3 3 2 2 1 0 0 0 0 11 325 1 11 12
84 88 74 80 81 87 88 6 2 2 4 3 3 8 4 4 3 3 3 4 4 3 3 3 2 0 0 0 0 0 6 175 0 10 10
89 88 76 105 111 95 96 7 3 3 2 2 3 7 5 4 4 4 3 4 4 4 2 3 2 1 0 0 0 0 6 175 0 8 12
98 97 90 121 125 110 101 8 4 2 2 3 2 8 6 3 3 4 3 3 3 4 4 2 2 0 0 0 0 0 10 275 0 8 10
83 86 76 97 98 86 90 6 3 3 2 2 3 6 4 3 3 4 3 3 4 4 3 2 2 0 0 0 0 0 6 175 0 9 14
86 87 84 93 94 87 88 6 2 2 2 3 2 6 3 4 4 3 3 4 4 3 3 2 2 0 0 0 0 0 5 150 0 10 12
84 87 80 82 85 91 96 8 4 4 2 3 3 8 6 4 4 4 3 3 3 4 4 2 2 0 0 0 0 0 6 175 0 12 14
84 89 91 112 114 94 89 6 4 3 3 3 3 8 6 4 4 4 4 2 2 3 3 3 2 0 0 0 0 0 12 325 0 14 10
104 97 107 93 96 78 81 8 6 3 3 5 3 8 8 4 4 6 4 2 2 2 3 3 2 1 0 0 0 0 15 425 1 10 11
104 98 98 121 134 107 92 6 8 3 4 3 3 8 8 6 4 4 3 2 2 3 3 2 2 0 0 0 0 0 13 375 2 11 10
98 77 86 134 164 111 91 8 3 3 3 4 2 8 6 4 4 6 3 2 2 2 3 2 3 1 0 0 0 0 14 373 0 8 10
83 84 72 115 111 103 99 7 3 3 6 3 3 8 8 4 6 4 4 2 2 2 3 2 2 0 0 0 0 0 11 325 1 8 14
95 97 89 128 131 109 97 6 4 2 2 4 2 10 6 3 3 4 3 2 2 2 2 3 3 1 0 0 0 0 14 398 1 13 12
92 86 89 95 100 84 85 4 2 2 2 6 3 6 3 3 3 6 4 2 2 2 2 2 2 1 0 0 0 0 13 348 0 11 12
96 95 88 105 112 98 91 5 3 3 3 4 3 7 6 6 4 4 3 2 2 3 3 2 2 0 0 0 0 0 10 275 0 8 10
84 74 66 79 80 78 73 6 4 2 3 3 3 8 6 4 4 3 3 2 2 3 2 2 2 1 0 0 0 0 8 248 1 8 12
96 85 84 101 101 93 126 6 3 3 6 3 3 8 6 4 8 4 4 1 2 2 1 2 2 1 0 0 0 0 13 375 1 10 14
87 93 87 113 114 100 82 5 2 2 3 3 2 7 4 3 4 4 5 1 2 2 3 2 2 1 0 0 0 0 10 275 0 11 15
106 106 106 125 126 117 105 7 3 3 4 3 3 8 6 4 4 3 3 2 2 2 2 3 2 0 0 0 0 0 12 325 0 14 10
96 96 94 150 145 105 100 6 4 3 4 3 3 8 6 4 5 4 4 2 2 3 3 2 2 0 0 0 0 0 13 348 0 12 10
88 89 86 134 134 106 102 7 4 3 3 2 2 8 7 5 4 4 3 1 2 2 3 2 3 0 0 0 0 0 10 275 0 11 12
97 97 90 115 115 103 97 8 4 2 3 3 4 8 6 4 5 4 4 1 2 2 3 3 2 1 0 0 0 0 12 323 0 14 10
84 84 77 104 107 90 86 6 3 3 2 3 2 8 4 4 4 3 3 2 2 3 3 2 2 0 0 0 0 0 9 250 0 10 10
98 95 92 121 124 104 97 7 4 3 3 3 3 7 5 4 4 4 3 2 2 2 3 2 2 0 0 0 0 0 12 325 0 8 11
84 83 83 100 103 85 84 8 3 3 4 2 2 8 5 4 4 4 3 2 2 2 3 3 2 0 0 0 0 0 8 250 1 8 10
86 87 78 126 129 105 92 8 4 4 5 3 3 8 7 4 4 5 4 1 2 2 3 3 2 0 0 0 0 0 12 350 1 8 10
82 83 77 87 89 88 93 6 2 2 3 3 3 6 4 4 5 4 3 2 3 3 2 2 2 0 0 0 0 0 6 175 0 10 12
96 92 75 118 122 101 107 8 5 3 3 2 2 8 8 4 5 4 3 1 2 2 2 3 3 1 0 0 0 0 10 300 1 10 12
101 86 82 114 116 86 92 7 4 4 3 3 3 7 5 4 4 4 4 2 2 2 3 2 2 0 0 0 0 0 12 325 0 8 14
103 102 95 127 127 114 101 8 5 3 3 5 3 8 6 4 4 6 4 1 2 2 2 3 3 0 0 0 0 0 13 375 1 11 12
87 86 86 126 129 109 99 6 3 3 8 4 3 6 6 4 8 5 4 1 2 2 2 2 2 0 0 0 0 0 14 375 0 12 10
97 96 94 111 114 91 95 7 4 3 3 2 2 7 5 4 4 4 4 2 2 2 3 3 2 1 0 0 0 0 11 325 1 8 10
84 86 81 103 103 85 89 6 3 3 3 4 3 8 6 4 4 4 3 2 2 2 3 2 2 0 0 0 0 0 10 275 0 10 12
84 84 82 103 105 91 86 6 4 3 3 3 2 7 5 4 3 3 3 2 2 3 3 2 2 0 0 0 0 0 8 225 0 8 14
88 87 84 95 96 83 88 7 4 4 3 3 3 8 6 4 4 4 3 2 3 3 3 2 2 0 0 0 0 0 9 275 1 11 11
94 90 88 120 125 115 103 8 4 3 3 3 2 8 6 4 4 4 3 2 2 2 2 3 3 0 0 0 0 0 10 300 1 10 12
98 97 89 132 133 117 105 7 4 3 3 5 3 8 6 4 4 6 4 1 2 2 2 2 3 1 0 0 0 0 13 375 1 8 10
COMPLICATIONS    FENTANYL REQUIREMENT MEAN BLOOD PRESSURE  VISUAL ANALOG SCALE - REST RAMSAY SEDATION SCALEVISUAL ANALOG SCALE - MOVEMENT
 
 
PREMEDICATION WITH ORAL PREGABALIN ON ATTENUATION OF HEMODYNAMIC PRESSOR 
RESPONSE TO LARYNGOSCOPY AND INTUBATION     
NAME:      AGE/SEX:   DATE: 
UNIT:      IP NO’:    WARD: 
DIAGNOSIS:     PROCEDURE: 
ASA-      GROUP:   BODY WEIGHT: 
PRE-OPERATIVE: 
1.Comorbid illness -   2.Medications -     3.Airway 
PRE-MEDICATIONS:   DOSE   ROUTE   DATE/TIME 
1.Tab.Ranitidine   150mg   p/o 
2.Tab.Alprazolam   0.5mg   p/o 
3. 
INTRA-OPERATIVE PERIOD: 
Midazolam-   Glycopyrrolate-   Fentanyl-      
Thiopentone-     Succinylcholine- 
LARYNGOSCOPY:  C.L-    DURATION- 
Maintenance- 
Total fentanyl-    Total atracurium-     
Reversal-      Extubated 
Duration of procedure -    Duration of anesthesia  - 
Delayed recovery -  PONV-    Shivering- 
HEMODYNAMIC PARAMETERS: 
 RSS HR SBP DBP MAP SPO2 
BASELINE       
AFTER PREMEDICATION     _      
AFTER INDUCTION     _      
 
AFTER LARYNGOSCOPY AND INTUBATION: 
 HR SBP DBP MAP SPO2 
IMMEDIATELY (0 MIN)      
1 MIN      
3 MIN      
5 MIN      
 
 PACU OBSERVATION:  Admission-  Discharge-  Stay- 
PCA:Started-   Concluded-  Duration- 
Drug-    Concentration- 10 mcg/ml  Loading- 
Demand-   Lockout-  Infusion- Nil 
Additional dose- 
 RSS               VAS HR RR BP SPO2 Additional dose 
Rest Movement 
         
         
         
         
         
         
         
         
         
 
Total demands-   good ones-  Total dosage- 
 ADVERSE EFFECTS: 
Events Treatment Remarks 
   
   
   
   
                                              
                                                            PATIENT CONSENT FORM 
Study title : EVALUATION OF ORAL PREGABALIN PREMEDICATION ON ATTENUATION OF HEMODYNAMIC 
RESPONSE TO LARYNGOSCOPY AND AS ADJUVANT IN ACUTE PAIN MANAGEMENT IN NORMOTENSIVE 
PATIENTS  
 
 
Study centre    :           Institute of Anaesthesiology and Critical Care, 
                                       Rajiv Gandhi Memorial Govt General Hospital, Chennai. 
 
 
Participant name :                                                Age:                         Sex:                                I.P.No: 
 
                  
 I confirm that i have understood the purpose of procedure for the above study. i have the 
opportunity to ask the question and all my questions and doubts have been answered to my 
satisfaction. 
                      
 I have been explained about the pitfall in the procedure.  I have been explained about the 
safety, advantage and disadvantage of the technique. 
 
 I understand that my participation in the study is voluntary and that i am free to withdraw at 
anytime without giving any reason. 
 
 I understand that investigator, regulatory authorities and the ethics committee will not need 
my permission to look at my health records both in respect to current study and any further 
research that may be conducted in relation to it, even if i withdraw from the study. I understand that 
my identity will not be revealed in any information released to third parties or published, unless as 
required under the law. I agree not to restrict the use of any data or results that arise from the 
study. 
 
Time:          
 
Date:                                                                                             signature / thumb impression of patient  
 
Place:                                                                                            patient name: 
 
Signature of the investigator: 
 
Name of the investigator: 
